Verici Dx plc (AIM: VRCI)
London
· Delayed Price · Currency is GBP · Price in GBX 4.025
-0.225 (-5.29%)
Jan 22, 2025, 11:02 AM GMT+1
Verici Dx Market Cap
Verici Dx has a market cap or net worth of 10.31 million as of January 22, 2025. Its market cap has decreased by -39.48% in one year.
Market Cap
10.31M
Enterprise Value
5.12M
Revenue
3.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.03
Market Cap Chart
Since November 3, 2020, Verici Dx's market cap has decreased from 51.74M to 10.31M, a decrease of -80.08%. That is a compound annual growth rate of -31.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 10.31M | 9.68% |
| Dec 31, 2024 | 9.40M | -43.40% |
| Dec 29, 2023 | 16.61M | -22.00% |
| Dec 30, 2022 | 21.29M | -71.66% |
| Dec 31, 2021 | 75.13M | -9.40% |
| Dec 31, 2020 | 82.92M | 60.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.37B |
| GSK plc | 55.43B |
| Haleon | 33.25B |
| Smith & Nephew | 9.04B |
| ConvaTec Group | 4.92B |
| Hikma Pharmaceuticals | 4.68B |
| HUTCHMED (China) | 1.94B |
| Oxford Nanopore Technologies | 1.48B |